Lehne Chapter 69 Flashcards
Immunosuppressants
Inhibit immune response
Uses
Prevention of organ rejection
Treatment of autoimmune diseases
Toxicity
Increased risk of infection
Increased risk of neoplasms
Calcineurin Inhibitors
Principal use: Prevention of organ rejection in transplant recipients
Cyclosporine, tacrolimus, pimecrolimus: Most effective immunosuppressants available
Differ in structure, but share the same mechanism
Inhibition of calcineurin suppresses production of interleukin (IL-2)
IL-2 needed for T-cell proliferation
Cyclosporine was developed first and is used more than tacrolimus
Cyclosporine [Sandimmune]
Mechanism
Suppresses the production of IL-2, interferon gamma, and other cytokines
Therapeutic uses
Drug of choice for organ rejection (kidney, liver, and heart) of an allogenic transplant
Some autoimmune diseases
Pharmacokinetics
Adverse effects
Nephrotoxicity
Infection
Hepatotoxicity
Lymphoma
Hypertension
Tremor
Hirsutism
Leukopenia, gingival hyperplasia, gynecomastia, sinusitis, hyperkalemia
Anaphylactic reactions
Drug and food interactions
Drugs that can decrease cyclosporine levels
Drugs that can increase cyclosporine levels
Nephrotoxic drugs
Grapefruit juice
Repaglinide
Neoral or Gengraf
Rheumatoid arthritis
Psoriasis
Tacrolimus [Prograf]
An alternative to cyclosporine
Somewhat more effective, but also more toxic
Narrow therapeutic index
Concurrent use with glucocorticoids
Therapeutic use
Prophylaxis of organ rejection (liver, kidney, or heart)
Mechanism of action
Adverse effects
Nephrotoxicity is the major concern
Neurotoxicity
Gastrointestinal (GI) effects
Hypertension
Hyperkalemia Adverse effects (Cont.)
Hyperglycemia
Hirsutism
Gum hyperplasia
Anaphylaxis with IV administration
Drug and food interactions
Agents that inhibit CYP3A (isozyme of cytochrome P450)
Grapefruit juice
Nonsteroidal antiinflammatory drugs (NSAIDs) should be avoided
mTOR Inhibitors
Enzyme known as mammalian target of rapamycin (mTOR)
Protein kinase that helps regulate cell growth, proliferation, and survival
Structurally similar to tacrolimus
Somewhat different mechanism
Does not involve inhibition of calcineurin
Sirolimus [Rapamune]
Actions and therapeutic use
Only for prevention of renal transplant rejection
Used in conjunction with cyclosporine and glucocorticoids
Adverse effects
Increased risk of infection
Raises levels of cholesterol and triglycerides
Risk of renal injury
Severe complications in the liver and lung
Rash, acne, anemia, thrombocytopenia, joint pain, diarrhea, hypokalemia
Drug and food interactions
Drugs that inhibit or induce CYP3A4
High-fat foods
Grapefruit juice
Everolimus [Zortress]
Therapeutic use
Mechanism of action
Adverse effects
Peripheral edema
Constipation
Hypertension
Nausea
Anemia
Urinary tract infection
Hyperlipidemia
Effects in pregnancy and lactation
Drug and food interactions
Drugs that inhibit or induce CYP3A4
High-fat foods
Grapefruit juice
Glucocorticoids
Used to widely suppress immune response
Suppression of allograft rejection, treatment of asthma, rheumatoid arthritis, systemic lupus erythematosus (SLE), and multiple sclerosis
Large doses used to prevent rejection
Increased risk of infection, thinning of skin, bone dissolution with fracture, impaired growth in children, and suppression of hypothalamic-pituitary-adrenal axis
Cytotoxic Drugs
Suppress immune response by killing B and T lymphocytes undergoing proliferation
Nonspecific: Toxic to all proliferating cells
Adverse effects
Bone marrow suppression
Neutropenia
Thrombocytopenia
GI disturbances
Reduced fertility
Alopecia
Azathioprine [Imuran]
Suppresses cell-mediated and humoral immune responses
Therapeutic uses
Adjuvant treatment with transplants
Autoimmune disorders
Adverse effects
Blood dyscrasias
Nausea and vomiting
Mutagenic and teratogenic
Neoplasms
Pancreatitis
Cyclophosphamide
Anticancer drug
Methotrexate [Rheumatrex, Trexall]
Rheumatoid arthritis
Psoriasis
Suppression of B and T lymphocytes by interfering with folate metabolism
Mitoxantrone [Novantrone]
Anticancer agent
Reduction of neurologic disability and clinical relapse for multiple sclerosis (MS) patients
Hazardous drug reserved for patients who are not responsive to safer drugs
Mycophenolate mofetil
Approved for prophylaxis of organ rejection
Acts on B and T lymphocytes to inhibit inosine monophosphate dehydrogenase
Selective inhibition of B- and T-lymphocyte proliferation